Fetal Cardiac Effects of Tocolytic Nifedipine and Magnesium Sulfate

NCT06904534 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-11-18

No results posted yet for this study

Summary

The potential unexpected effects of nifedipine and MgSO4, the tocolytic agents used for the indication of preterm labor, on fetal heart will be determined. In this study, the fetal echocardiographic findings of nifedipine and MgSO4 will be compared.

Conditions

  • Unexpected Fetal Cardiac Effects of Nifedipine and MgSO4

Sponsors & Collaborators

  • Sanliurfa Education and Research Hospital

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2025-06-30
Completion
2025-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06904534 on ClinicalTrials.gov